Authors
Loading...
In vitro study demonstrates novel FABP4 inhibitors attenuate inflammation in activated microglia, suggesting therapeutic potential for neurodegenerative diseases.
Low et al. (2025) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: